94.9 %In Togo, rapid POC testing had estimated sensitivity of 94.9% for HbAC phenotype.
Togodrépanocytosepublished 2018BMC hematologyeurope_pmcdocument of 7 observationsDOI 10.1186/s12878-018-0120-5
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
6 evidence items · page 1 / 1
97.6 %In Togo, rapid POC testing had estimated sensitivity of 97.6% for HbSS phenotype.
Togodrépanocytosepublished 2018BMC hematologyeurope_pmcdocument of 7 observationsDOI 10.1186/s12878-018-0120-5
95.6 %In Togo, rapid POC testing had estimated sensitivity of 95.6% for HbAS phenotype.
Togodrépanocytosepublished 2018BMC hematologyeurope_pmcdocument of 7 observationsDOI 10.1186/s12878-018-0120-5
99.2 %In Togo, rapid POC testing had specificity exceeding 99.2% for all phenotypes.
Togodrépanocytosepublished 2018BMC hematologyeurope_pmcdocument of 7 observationsDOI 10.1186/s12878-018-0120-5
97.7 %In Togo, rapid POC testing had estimated sensitivity of 97.7% for HbSC phenotype.
Togodrépanocytosepublished 2018BMC hematologyeurope_pmcdocument of 7 observationsDOI 10.1186/s12878-018-0120-5
97.6 %In Togo, the Sickle SCAN® rapid POC test showed estimated sensitivity of 97.6% for HbSS phenotype.
Togodrépanocytosepublished 2018BMC HematologyOpenAlexdocument of 8 observationsDOI 10.1186/s12878-018-0120-5
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.